CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Consolidated net income	$ 74,051	$ 50,331	$ 44,521
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	53,158	43,394	38,293
Provision for inventory excess and obsolescence	2,988	3,627	4,002
Share-based compensation	23,108	25,606	23,119
Deferred income taxes	(18,654)	(3,945)	(4,113)
Loss (gain) on disposal of fixed assets	(61)	65	120
Contingent consideration adjustments	(1,443)	(99)	(6,632)
Inventory acquisition fair value adjustments	160	1,411	188
Write-off of unamortized deferred financing costs	624
Non-cash interest expense	1,229	1,170	1,045
Other non-cash items	356	74	157
Changes in assets and liabilities which provided/(used) cash, excluding effects from business acquisitions:
Accounts receivable	(23,246)	(25,355)	18,026
Inventories	(48,547)	(19,078)	22,102
Prepaid expenses and other current assets	(814)	(3,117)	4,456
Prepaid income taxes, income taxes receivable and income taxes payable	489	(140)	6,015
Accounts payable, accrued expenses and other current liabilities	30,333	24,516	(14,484)
Other non-current assets and liabilities	(2,952)	(3,835)	3,424
Cash provided by operating activities	90,779	94,625	140,239
Cash flows from investing activities:
Purchases of property, plant and equipment	(19,643)	(19,976)	(10,524)
Acquisition of businesses, net of cash acquired and working capital adjustments	(21,565)	(284,728)
Payment of contingent consideration related to acquisition of technology assets	(1,470)	(2,200)	(2,632)
Proceeds from sale of property, plant and equipment	137	200
Cash used in investing activities	(42,541)	(306,704)	(13,156)
Cash flows from financing activities:
Borrowings under revolving credit facilities	69,941	280,000
Repayments under term loan and revolving credit facilities	(59,029)	(32,381)	(35,391)
Payments of debt issuance costs	(2,492)	(890)	(1,614)
Payments of withholding taxes from share-based awards	(11,721)	(30,830)	(8,554)
Payments of deferred and escrowed purchase price related to acquisitions			(31,021)
Payments of contingent considerations related to acquisitions	(46,254)	(1,836)	(1,135)
Repurchases of common shares	(10,000)		(5,500)
Purchase of building under finance lease		(8,743)
Other financing activities	(599)	(567)	(1,142)
Cash provided by (used in) financing activities	(60,154)	204,753	(84,357)
Effect of exchange rates on cash and cash equivalents	(5,372)	(335)	3,384
Increase (decrease) in cash and cash equivalents	(17,288)	(7,661)	46,110
Cash and cash equivalents, beginning of year	117,393	125,054	78,944
Cash and cash equivalents, end of year	100,105	117,393	125,054
Supplemental disclosure of cash flow information:
Cash paid for interest	14,264	6,207	5,529
Cash paid for income taxes	20,291	11,304	5,879
Income tax refunds received	169	1,557	4,833
Supplemental disclosure of non-cash investing activity:
Accruals for capital expenditures	$ 1,681	$ 708	$ 166